South Africa Reboots Tobacco Control Act: Planning to Unify the Package of Vapes

Regulations by 2FIRSTS.ai
Aug.14.2024
South Africa Reboots Tobacco Control Act: Planning to Unify the Package of Vapes
South Africa's Tobacco Control and Electronic Delivery Systems Bill has been reintroduced by parliament, aiming to enhance public health measures.

According to BusinessTech's report on August 13th, the South African "Tobacco Products Control and Electronic Delivery Systems Bill" has been revived by Parliament after lapsing at the end of the previous government's term, and has now entered the further processing stage. The bill was first introduced in December 2022 in the National Assembly and has now been included in the agenda of the seventh government.


According to reports, the proposed bill aims to strengthen public health protection measures by aligning current smoking control legislation with the requirements of the World Health Organization's Framework Convention on Tobacco Control. The legislation under consideration would regulate the sale, advertising, and use of tobacco products and electronic delivery systems. Specific provisions include:


Strengthening the standards for the processing, manufacturing, and importing of products and related products.


Regulate advertising of tobacco products and electronic delivery systems.


Standardizing the packaging and appearance of tobacco and electronic delivery system products.


Smoking is prohibited in all indoor public areas and "designated outdoor areas.


Prohibition of cigarette vending machines.


Mandatory adoption of "simplified packaging with graphic health warnings";


It is prohibited to display tobacco products and electronic delivery systems at retail locations.


The reintroduction of this bill has provoked mixed reactions. Dr. Sharon Nyatsanza of the National Coalition Against Smoking (NCAS) stated that this legislation is an important step towards promoting a healthier society. She said:


By aligning domestic legislation with global standards, a strong tobacco control policy is crucial in reducing the burden of non-communicable diseases in South Africa and supporting the sustainable implementation of national health insurance. The measures in this bill will help reduce tobacco use, exposure to secondhand smoke, and youth smoking.


Dr. Catherine Egbe, head of the Global Adult Tobacco Survey in South Africa (GATS-SA), emphasized the need to pass the bill as soon as possible.


According to GATS-SA data, 29.4% of individuals aged 15 and over, totaling 12.7 million people, are using tobacco, facing serious health risks such as cancer, cardiovascular diseases, and respiratory diseases. The phenomenon of adolescents using e-cigarettes is also on the rise, raising concerns about nicotine addiction and long-term health effects, especially on the developing brains of young people.


Dr. Egbe stated that the proposed measures in the bill are an effective strategy to reduce tobacco and e-cigarette use, and should be urgently implemented, along with an increase in taxes.


Our government has access to all the research that can support every evidence-based measure in the bill and should not be influenced by misleading information.


It has been reported that the National Assembly Health Committee, a former parliamentary subcommittee, had called for written submissions on the bill. A nationwide public hearing subsequently ended in December 2023. Throughout this process, media statements from the committee largely indicated broad principle support for the bill's health-related objectives. However, there are still many pressing issues to be addressed at the operational level. These include:


The likelihood of an increase in illicit tobacco product trade.


The potential decrease in tax revenue from the production and sale of legal tobacco products and electronic delivery systems;


There is insufficient attention given to the impact on small and medium-sized informal traders, especially retailers of single cigarette sales.


Monitoring and enforcement capabilities are inadequate.


Despite the prevalence of the cigarette market in South Africa, illegal trade is rapidly growing. Opponents of the legislation believe that such laws could further fuel the development of the illegal market.


The South African Legal Academy (SA Legal Academy) mentioned:


Given these issues, it is currently unclear how the new National Assembly Health Committee will address them.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09